Abstract
Once upon a time, universities were ivory towers — or, at least, most people saw them as such. Academics prided themselves on not being influenced by, or answerable to, anyone except the academy, and perceived themselves as free from conflicts of interest arising from relationships with people or institutions outside the walls of the university. None of this holds true today and, as the case of Dr Nancy Olivieri illustrates, universities are facing some difficult times in adjusting to these changes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
27 March 2018
This article was initially published with an incorrect DOI that did not match the registered version at Crossref. The DOI has been corrected in the article.
References
Thompson, J., Baird, P. & Downie, J. The Report of the Committee of Inquiry on the Case Involving Dr Nancy Olivieri, The Hospital for Sick Children, the University of Toronto, and Apotex, Inc. (Can. Assoc. Univ. Teachers, Ottawa, Canada, 2001).
Le Carré, J. The Constant Gardner (Simon and Schuster, USA, 2000).
Naimark, A., Knoppers, B. M. & Lowy, F. H. Commentary on selected aspects of the report of the Canadian Association of University Teachers Committee of Inquiry on the case involving Dr Nancy Olivieri, The Hospital for Sick Children, the University of Toronto, and Apotex, Inc. [online] (cited 12 Feb. 02) 〈http://www.sickkids.on.ca/MediaRoom/CAUTfinal2ed.pdf〉 (2001).
Thompson, J., Baird, P. & Downie, J. Supplement to the Report of the Committee of Inquiry on the Case Involving Dr Nancy Olivieri, The Hospital for Sick Children, the University of Toronto, and Apotex, Inc. (Can. Assoc. Univ. Teachers, Ottawa, Canada, 2002).
Diav-Citrin, O., Atanackovic, G. & Koren, G. An investigation into variability of the therapeutic response to deferiprone in patients with thalassemia major. Therap. Drug Monitor. 21, 7–81 (1999).
The College of Physicians and Surgeons of Ontario. Complaints Committee Decision and Reasons. Complainant: Dr Laurence Becker, Respondent: Dr Nancy Olivieri. No. 44410, 19 Dec 2001.
Quick, J. Maintaining the integrity of the clinical evidence base. Bull. World Health Org. 79, 1093 (2001).
Montaner, J. S. G., O'Shaughnessy, M. V. & Schechter, M. T. Industry-sponsored clinical research: a double-edged sword. Lancet 358, 1893–1895 (2001).
Davidoff, F. et al. Sponsorship, authorship, and accountability. N. Engl. J. Med. 345, 825–826 (2001).
Martin, J. B. & Kasper, D. L. In whose best interest? Breaching the academic–industrial wall. N. Engl. J. Med. 343, 1646–1649 (2000).
Bodenheimer, T. Uneasy alliance — clinical investigators and the pharmaceutical industry. N. Engl. J. Med. 342, 1539–1544 (2000).
Angell, M. Is academic medicine for sale? N. Engl. J. Med. 342, 151–158 (2000).
Salomon, J. J. Science policies in a new setting. Int. Soc. Sci. J. 168, 323–335 (2001).
Somerville, M. The Ethical Canary: Science, Society and the Human Spirit (Viking/Penguin, Toronto, 2000).
Parizeau, M.-H. Are the universities and sciences subservient to the economy? A summary and analysis. ISUMA Can. J. Policy Res. 2, 123–132 (2002).
Jacobs, J. Systems of Survival: A Dialogue on the Moral Foundations of Commerce and Politics (Random House, New York, 1992).
Katz, J. The Silent World of Doctor and Patient (Free, New York, 1984).
30C/Resolution 21 on follow-up to the World Conference on Science and implementation of its recommendations. Gen. Conf. UNESCO (August 18, 1999).
Author information
Authors and Affiliations
Related links
Rights and permissions
About this article
Cite this article
Somerville, M. A postmodern moral tale: the ethics of research relationships. Nat Rev Drug Discov 1, 316–320 (2002). https://doi.org/10.1038/nrd774
Issue Date:
DOI: https://doi.org/10.1038/nrd774
This article is cited by
-
Patients’ health or company profits? The commercialisation of academic research
Science and Engineering Ethics (2003)
